检索

标题
作者
Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice
Kolyadina I., Abidova N., Akopyan A., Antonova G., Arapova O., Bobrova E., Bolotina L., Valiakhmetova C., Vasilevskaya A., Vladimirova L., Volkonskiy M., Ganshina I., Gudkova I., Dergunov A., Evstigneeva I., Egurenkova V., Emshanov A., Zhukova L., Zueva E., Karabina E., Kolokolov J., Kuzmicheva S., Kuchevskaya O., Luev I., Maistrenko K., Markizova E., Marfutov V., Medvedev S., Merzlikina Y., Nersesova T., Ovchinnikova E., Orlova S., Samaneva N., Stativko O., Storozhakova A., Stroyakovskiy D., Sultanbaev A., Tekeeva A., Fadeeva N., Fedorova A., Shalaeva O., Shangina I., Shirokova O., Shumskikh A., Yakubova M.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I., Poddubnaya I.
Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia
Gorbunova V., Kolyadina I., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Filonenko D., Zhilyaeva L., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Suslova I., Romanchuk O., Kozlov D., Rzaev A., Marfutov V., Andreiashkina I., Vladimirova L., Mitashok I., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Morozov D., Prokof'eva E., Kramskaia L., Karandeeva T., Evstigneeva I., Ovchinnikova E., Klement'eva T., Khrupalo O., Tiuvinova E., Sherstnev V., Chernov I., Kolokolov D., Gaisina E., Levchenko N., Chubenko V., Povyshev A., Iudina I., Vorotilina L., Andreeva T., Tumanian G., Koziakov A., Gil'mutdinova L., Osipov M., Shatokhina A., Vazhenina A., Chichkanova A., Vladimirov V., Ivanov A., Belokhvostova A., Cherniakova E., Tul'china E., Maklashova S., Shkodenko O., Kostalanova I., Tarasova A., Kuz'mina E.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.
The results of the first retrospective data analysis of eribulin application in patients with metastatic breast cancer in actual clinical practice in Russia
Bolotina L., Manziuk L., Gorbunova V., Kovalenko E., Mukhametshina G., Khasanova A., Vladimirova L., Mitashok I., Prokofyeva E., Evstigneeva I., Andreyashkina I., Abramova N., Popova I., Karabina E., Teterich A., Gaysina E., Chubenko V., Limareva S., Tikhanovskaya N., Storozhakova A., Samaneva N., Svetitskaya Y., Snezhko T., Kalabanova E.
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Karabina E., Zhukova L.
Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience
Kolyadina I., Ganshina I., Kuzmicheva S., Tekeeva A., Kolokolov J., Volkonskii M., Poddubnaya I.
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Semiglazova T., Klyuge V., Semiglazov V., Teletaeva G., Krivorotko P., Dashyan G., Paltuev R., Tkachenko E., Donskikh R., Semiglazov V.
The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
Kovalenko E., Artamonova E., Karabina E., Andreiashkina I., Prokof’eva E., Popova N., Gaisina E., Evstigneeva I., Shaidorov M., Zhiliaeva L., Ponomarenko D., Khasanova A., Mukhametshina G., Koziakov A., Vorotilina L., Povyshev A., Simolina E., Marfutov V., Kozlov D., Suslova I., Shikina V., Karandeeva T., Shepel’ A., Kramskaia L., Oskirko D., Frolova O.
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Artamonova E., Gorbunova V., Zhukov N., Manzjuk L., Manihas A., Paltuev P., Semiglazov V., Semiglazova T., Stenina M., Tjuljandin S., Chubenko V.
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Kolyadina I., Bulavina I., Petkau V., Strakhova N., Gorbunova V., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Gan'shina I., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Khokhlova S., Filonenko D., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Vladimirova L., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Orlov A., Kostalanova I., Levchenko N., Osipov M., Karandeeva T., Evstigneeva I., Chernov I., Kolokolov D., Povyshev A., Shatokhina A., Cherniakova E., Shkodenko O., Kuz'mina E.
1 - 11 的 11 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##